Amwell® to report fourth quarter and full year 2024 operating results
- 58
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell Logo are registered trademarks of American Well Corporation.
Investors: Sue Dooley 415.602.9167 [email protected] Media: Angela Vogen [email protected]
GlobeNewswire ist eines der weltweit größten Nachrichtennetzwerke, das sich auf die Verbreitung von Pressemitteilungen, Finanzinformationen und Multimedia-Inhalten an Medien, Investoren und Leser weltweit spezialisiert hat.
- EQS-News: Neuer Aufsichtsratsvorsitzender der Baader Bank gewählt
- EQS-Adhoc: Aufsichtsrat der Baader Bank wählt neuen Vorsitzenden
- FundBank (Europe) S.A. von der Europäischen Zentralbank als luxemburgisches Kreditinstitut zugelassen
- EQS-News: Affluent Medical gibt erfolgreiche 10. Implantation seines künstlichen Harnröhrenschließmuskels Artus bekannt und schließt damit die Pilotstudie ab
- EQS-Adhoc: Versagung des Bestätigungsvermerks für den Jahresabschluss und Lagebericht für das Geschäftsjahr 2023
- Piramal Pharma Limited gibt Ergebnisse für das 3. Quartal (Q3) und die ersten 9 Monate des Geschäftsjahres 2025 (9MGJ25) bekannt